加味红藤败酱汤联合西药治疗湿热瘀阻型慢性盆腔炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R711.33

基金项目:


Clinical Study on Modified Hongteng Baijiang Decoction Combined with Western Medicine for Chronic Pelvic Inflammatory Disease of Damp- Heat Stasis Obstruction Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察加味红藤败酱汤联合西药治疗湿热瘀阻型慢性盆腔炎(CPID) 的临床疗效。方法:将 136 例湿热瘀阻型CPID 患者随机分成对照组和观察组各68 例,2 组均予左氧氟沙星片与甲硝唑片联合治疗, 观察组加用加味红藤败酱汤治疗。2 组均以2 周为1 个疗程,治疗2 个疗程。治疗前后评定下腹部、腰骶部疼 痛视觉模拟评分法(VAS) 评分、中医证候评分及体征评分、生活质量评分,检测炎症因子[C-反应蛋 白(CRP)、白细胞介素-6 (IL-6)、白细胞介素-8 (IL-8)、肿瘤坏死因子-α (TNF-α)]、血液流变学指 标(全血高切黏度、全血低切黏度、血浆黏度、红细胞压积),评估治疗后的临床疗效,并记录治疗期间患者 出现的不良反应。结果:治疗2 个疗程后,观察组总有效率92.65%,对照组总有效率70.59%,2 组比较,差 异有统计学意义(P<0.05)。2 组中医证候积分、体征积分及下腹部、腰骶部疼痛VAS 评分均较治疗前下 降(P<0.05),观察组4 项评分值均低于对照组(P<0.05)。2 组心理、生理、环境、社会评分均较治疗前升 高(P<0.05),观察组4 项评分均高于对照组(P<0.05)。2 组血清CRP、IL-6、IL-8、TNF-α 水平及全血高 切黏度、全血低切黏度、血浆黏度、红细胞压积值均较治疗前下降(P<0.05),观察组8 项指标值均低于对照 组(P<0.05)。2 组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:加味红藤败酱汤联合西药治 疗湿热瘀阻型CPID 可提高临床疗效,增强抗炎作用,有效缓解疼痛等相关症状,提高患者的生活质量,且安 全性良好。

    Abstract:

    Abstract: Objective: To observe the clinical effect of the therapy of modified Hongteng Baijiang Decoction combined with western medicine on chronic pelvic inflammatory disease (CPID) of damp- heat stasis obstruction type. Methods:A total of 136 CPID patients of damp-heat stasis obstruction type were randomly divided into the control group and the observation group,with 68 cases in each group. The two groups were given Levofloxacin Tablets and Metronidazole Tablets for treatment, and the observation group was additionally treated with modified Hongteng Baijiang Decoction. With 2 weeks as a course of treatment, the two groups were treated for 2 courses. Before and after treatment, the scores of Visual Analogue Scale (VAS) for pain in lower abdomen and lumbosacral portion, traditional Chinese medicine (TCM) syndrome scores and signs scores, and quality of life scores were evaluated; the inflammatory factors,including C-reactive protein (CRP),interleukin-6 (IL-6),interleukin-8 (IL-8) and tumor necrosis factor- α (TNF- α), and indexes of hemorheology, including whole blood high- shear viscosity, whole blood low- shear viscosity, plasma viscosity and erythrocyte sedimentation rates were detected; the clinical effects were evaluated after treatment, and adverse reactions were recorded during treatment. Results:After 2 courses of treatment,the total effective rate was 92.65% in the observation group and 70.59% in the control group, the difference being significant (P<0.05). The TCM syndrome scores and signs scores,and VAS scores for pain in the lower abdomen and lumbosacral portion in both groups were decreased when compared with those before treatment (P<0.05);the above four scores in the observation group were lower than those in the control group (P<0.05). The scores of psychology, physiology, environment and society in the two groups were increased when compared with those before treatment (P<0.05),and the above four scores in the observation group were higher than those in the control group (P<0.05). The levels of serum CRP, IL- 6, IL- 8, and TNF- α, and whole blood high- shear viscosity, whole blood low- shear viscosity, plasma viscosity and erythrocyte sedimentation rates in both groups were decreased when compared with those before treatment (P<0.05), and the above eight indexes of hemorheology in the observation group were lower than those in the control group (P<0.05). There was no significant difference being found in the comparison of incidence of adverse reactions between the two groups (P>0.05). Conclusion: The therapy of modified Hongteng Baijiang Decoction combined with western medicine for CPID of damp-heat stasis obstruction type can enhance the clinical effect and antiinflammatory effect, effectively mitigate relevant symptoms of pain, and improve the quality of life of patients with good safety.

    参考文献
    相似文献
    引证文献
引用本文

王新霞,黄秋阳,龚杏姿.加味红藤败酱汤联合西药治疗湿热瘀阻型慢性盆腔炎临床研究[J].新中医,2023,55(10):68-74

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-05-25
  • 出版日期:
文章二维码